Cebelina Trio Tablets
Cebelina Trio Tablets
Composition: Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin Hydrochloride (SR) 500 mg Tablets
Additional Details:
| Packing Size | 10×10 Strip |
| Form | Tablets |
Brand Name: Cebelina Trio Tablets
Description:
Cebelina Trio Tablets are a comprehensive pharmaceutical formulation tailored to manage Type 2 Diabetes Mellitus effectively. The combination of Linagliptin, Dapagliflozin, and Metformin Hydrochloride (Sustained Release) provides a multifaceted approach to controlling blood sugar levels.
Linagliptin: A DPP-4 inhibitor that enhances the incretin system, promoting insulin secretion and reducing glucose production.
Dapagliflozin: A selective SGLT2 inhibitor that helps the kidneys remove excess glucose through urine, supporting better glycemic control.
Metformin Hydrochloride (SR): A cornerstone in diabetes management, reducing hepatic glucose production and improving insulin sensitivity for sustained effectiveness throughout the day.
These tablets are ideal for patients requiring dual or triple therapy to maintain glycemic control, prevent diabetes-related complications, and improve overall quality of life.